🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,40 USD

Máx. histórico

119,27

4270 días

Caída desde máximo

-69,48%

Rango 52 semanas

18,80 – 36,67

Variación hoy

+0,03%

Cierre anterior

36,39

Rango de hoy

36,38 – 36,45

Volumen hoy

2.420.374

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,36%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
104,00 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 7 horas
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
10/02/2021 75,63 77,90 73,72 77,29 +2,72% 5,53% 467.400
09/02/2021 75,57 76,83 74,72 75,24 -0,71% 2,79% 337.700
08/02/2021 74,95 76,18 73,00 75,78 +2,41% 4,24% 373.700
05/02/2021 72,21 74,38 70,97 74,00 +3,28% 4,72% 360.800
04/02/2021 71,67 72,39 69,59 71,65 +0,25% 3,91% 472.400
03/02/2021 69,57 72,02 69,57 71,47 +2,67% 3,52% 436.000
02/02/2021 71,62 71,62 67,64 69,61 -0,53% 5,56% 401.100
01/02/2021 66,44 70,34 66,34 69,98 +5,90% 6,02% 503.500
29/01/2021 67,64 69,21 65,01 66,08 -1,27% 6,21% 547.500
28/01/2021 69,85 73,83 66,60 66,93 -2,83% 10,35% 811.900
27/01/2021 67,39 71,17 66,35 68,88 +0,42% 7,15% 657.000
26/01/2021 70,47 70,95 68,31 68,59 -1,73% 3,75% 260.000
25/01/2021 68,18 70,86 67,15 69,80 +2,86% 5,44% 431.300
22/01/2021 68,77 69,55 66,84 67,86 -2,43% 3,94% 639.000
21/01/2021 71,61 71,72 66,59 69,55 -5,17% 7,16% 868.100
20/01/2021 74,64 75,11 71,84 73,34 -0,69% 4,38% 483.600
19/01/2021 74,13 74,99 71,40 73,85 +0,23% 4,84% 376.800
15/01/2021 74,50 77,45 73,23 73,68 -4,51% 5,66% 550.600
14/01/2021 73,99 77,89 73,50 77,16 +4,99% 5,93% 743.100
13/01/2021 73,32 74,24 71,77 73,49 +0,63% 3,37% 548.000
12/01/2021 71,50 74,04 71,19 73,03 +2,13% 3,99% 381.700
11/01/2021 69,28 72,58 69,28 71,51 +1,95% 4,76% 526.200
08/01/2021 68,59 72,06 68,44 70,14 +3,65% 5,28% 1.072.600
07/01/2021 64,03 70,08 63,33 67,67 +7,50% 10,54% 1.356.300
06/01/2021 60,81 64,30 60,80 62,95 +4,08% 5,76% 791.400
05/01/2021 58,97 60,87 58,97 60,48 +1,97% 3,22% 368.000
04/01/2021 60,10 60,58 57,72 59,31 -0,89% 4,76% 706.800
31/12/2020 58,63 60,07 56,90 59,84 +1,92% 5,41% 245.500
30/12/2020 60,29 60,68 58,69 58,71 -0,76% 3,30% 219.300
29/12/2020 58,50 59,30 56,84 59,16 +1,34% 4,21% 375.800